[S2] シンポジウム2「Onvolytic virus and cell-based therapy」

[S2-2] 悪性黒色腫軟膜播種に対する抗がんウイルスを用いた新規遺伝子改変間葉系幹細胞治療の開発

^○金谷 信彦^1,2, Shinji Kuroda¹, 藤原 俊義¹, Khalid Shah² (1.岡山大学病院 消化管外科, 2.ハーバード大学医学部大学院　ブリガム・アンド・ウィメンズ病院　脳神経外科)

キーワード：Oncolytic virus, Gene edited and engineered cell based therapy, Gastroenterological surgery, Cancer, Brain metastasis

2023.4- Clinical Fellow, Department of Gastroenterological Surgery, Okayama University Hospital, Okayama, Japan
2019-2023.3  Research fellow, Center for Stem and Translational Immunotherapy (CSTI), Department of Neurosurgery, Brigham and Women’s hospital, Harvard medical school, Boston, MA, USA
2018–2019     Clinical Fellow, Department of Gastroenterological Surgery, Okayama University Hospital, Okayama, Japan
2017–2018     Director, Medical Affairs Division, Okayama Juvenile Training School, Okayama, Japan
2015–2016     Clinical Fellow, Department of Gastroenterological Surgery, Okayama University Hospital, Okayama, Japan
2012–2015     Senior Resident, Department of Surgery, Iwakuni Clinical Center, Iwakuni, Japan
2011–2012     Junior Resident, Iwakuni Clinical Center, Iwakuni, Japan
2010–2011     Junior Resident, Okayama University Hospital, Okayama, Japan